Scpharmaceuticals Stock Today
| SCPH Stock | USD 4.50 0.11 2.39% |
Performance0 of 100
| Odds Of DistressOver 85
|
Scpharmaceuticals is trading at 4.50 as of the 24th of April 2024. This is a -2.39 percent decrease since the beginning of the trading day. The stock's open price was 4.61. Scpharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Scpharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of February 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of November 2017 | Category Healthcare | Classification Health Care |
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company has 36.05 M outstanding shares of which 4.62 M shares are at this time shorted by private and institutional investors with about 16.78 trading days to cover. More on Scpharmaceuticals
Moving together with Scpharmaceuticals Stock
| 0.63 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Scpharmaceuticals Stock
| 0.71 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.71 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.52 | ELYM | Eliem Therapeutics | PairCorr |
| 0.52 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Scpharmaceuticals Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Scpharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Scpharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | John Tucker | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Scpharmaceuticals report their recommendations after researching Scpharmaceuticals' financial statements, talking to executives and customers, or listening in on Scpharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Scpharmaceuticals. The Scpharmaceuticals consensus assessment is calculated by taking the average forecast from all of the analysts covering Scpharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Scpharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Scpharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Scpharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scpharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Scpharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scpharmaceuticals' financial leverage. It provides some insight into what part of Scpharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scpharmaceuticals (SCPH) is traded on NASDAQ Exchange in USA. It is located in 25 Mall Road, Burlington, MA, United States, 01803 and employs 135 people. Scpharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 166.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Scpharmaceuticals's market, we take the total number of its shares issued and multiply it by Scpharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Scpharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 36.05 M outstanding shares of which 4.62 M shares are at this time shorted by private and institutional investors with about 16.78 trading days to cover.
Scpharmaceuticals currently holds about 55.85 M in cash with (59.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04.
Check Scpharmaceuticals Probability Of Bankruptcy
Ownership AllocationScpharmaceuticals maintains a total of 36.05 Million outstanding shares. The majority of Scpharmaceuticals outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Scpharmaceuticals to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Scpharmaceuticals. Please pay attention to any change in the institutional holdings of Scpharmaceuticals as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Scpharmaceuticals Ownership Details
Scpharmaceuticals Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Scpharmaceuticals jumping above the current price in 90 days from now is roughly 97.0%. The Scpharmaceuticals probability density function shows the probability of Scpharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.1751. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Scpharmaceuticals will likely underperform. Additionally, scpharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Scpharmaceuticals to move above the current price in 90 days from now is roughly 97.0 (This Scpharmaceuticals probability density function shows the probability of Scpharmaceuticals Stock to fall within a particular range of prices over 90 days) .
Scpharmaceuticals Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Scpharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Scpharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Scpharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Tejara Capital Ltd | 2023-12-31 | 757.8 K | |
| Stempoint Capital Lp | 2023-12-31 | 567.2 K | |
| State Street Corporation | 2023-12-31 | 560.3 K | |
| Geode Capital Management, Llc | 2023-12-31 | 537.7 K | |
| Jefferies Financial Group Inc | 2023-12-31 | 500 K | |
| Millennium Management Llc | 2023-12-31 | 356.9 K | |
| Northern Trust Corp | 2023-12-31 | 269 K | |
| Kennedy Capital Management Inc | 2023-12-31 | 223 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 198.6 K | |
| Orbimed Advisors, Llc | 2023-12-31 | 5.6 M | |
| Rubric Capital Management Lp | 2023-12-31 | 3.5 M |
Scpharmaceuticals Historical Income Statement
Scpharmaceuticals Income Statement is one of the three primary financial statements used for reporting Scpharmaceuticals's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Scpharmaceuticals revenue and expense. Scpharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Scpharmaceuticals' Gross Profit is increasing as compared to previous years. The Scpharmaceuticals' current Other Operating Expenses is estimated to increase to about 72.4 M, while Operating Income is forecasted to increase to (52.6 M). View More FundamentalsScpharmaceuticals Stock Against Markets
Picking the right benchmark for Scpharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Scpharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Scpharmaceuticals is critical whether you are bullish or bearish towards Scpharmaceuticals at a given time. Please also check how Scpharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Scpharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Scpharmaceuticals Corporate Directors
Scpharmaceuticals corporate directors refer to members of a Scpharmaceuticals board of directors. The board of directors generally takes responsibility for the Scpharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Scpharmaceuticals' board members must vote for the resolution. The Scpharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Abhay Gandhi | Director | Profile | |
| Minnie BaylorHenry | Director | Profile | |
| Mason Freeman | Director | Profile | |
| Mette Agger | Director | Profile |
How to buy Scpharmaceuticals Stock?
Before investing in Scpharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Scpharmaceuticals. To buy Scpharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Scpharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Scpharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Scpharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Scpharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Scpharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.
Already Invested in Scpharmaceuticals?
The danger of trading Scpharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Scpharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Scpharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Scpharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Scpharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scpharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scpharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scpharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.353 | Return On Assets (0.32) | Return On Equity (1.00) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.